Lee James, MD, PhD, is a Senior Vice President of Global Medical Affairs in Oncology at Eli Lilly and Company since 2025. With a robust background in basic science, clinical trials, and medical practice, they excel in bridging the gap between scientific research and clinical medicine. Previously, Lee held various leadership roles at Bristol Myers Squibb and Pfizer, contributing significantly to the development of oncology therapies. They completed a PhD at the Fred Hutchinson Cancer Research Center and an MD at the University of Washington, further enhancing their expertise in the field.
This person is not in any teams
This person is not in any offices